Nuvara

Nuvara, Inc. is a medical device company based in Minneapolis, Minnesota, established in 2008. The company is dedicated to improving patient outcomes for individuals with obstructive lung diseases, such as COPD and asthma. Nuvara focuses on developing innovative therapies that target overactive airway nerves, which are commonly associated with these conditions. The company's flagship product is the dNerva® Lung Denervation System, a catheter-based technology used in a procedure called Targeted Lung Denervation (TLD). This outpatient procedure aims to preserve lung health by addressing the underlying issues of COPD. Nuvara holds over 70 patents worldwide and is led by a team of experienced professionals in various fields, including market development and clinical research. Nuvara primarily serves healthcare providers and patients seeking advanced treatment options for obstructive lung diseases. The company is positioned to enhance the standard of care in respiratory medicine with its minimally invasive treatment alternative.

• Employees7
• Founded1962